Skip to main content
SpringerLink
Log in
Book cover

Pharmacology and Therapeutics of Asthma and COPD

  • Book
  • © 2017

Overview

Editors:
  1. Clive P. Page

    1. Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King’s College London, London, United Kingdom

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Peter J. Barnes

    1. Airway Disease Section, Imperial College, National Heart and Lung Institute, London, United Kingdom

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Accessible overview of current and novel approaches to treatment of asthma and COPD

  • Well illustrated and comprehensive

  • Referenced as an authoritative update to two previous volumes in the series

Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 237)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (13 chapters)

  1. Front Matter

    Pages i-x
    Download chapter PDF

  2. Pathogenesis of COPD and Asthma

    • Clive Page, Blaze O’Shaughnessy, Peter Barnes
    Pages 1-21

  3. β2 Agonists

    • Charlotte K. Billington, Raymond B. Penn, Ian P. Hall
    Pages 23-40

  4. Muscarinic Receptor Antagonists

    • Maria Gabriella Matera, Mario Cazzola
    Pages 41-62

  5. Xanthines and Phosphodiesterase Inhibitors

    • D. Spina, C. P. Page
    Pages 63-91

  6. Glucocorticosteroids

    • Peter J. Barnes
    Pages 93-115

  7. Fixed-Dose Combination Inhalers

    • Mario Cazzola, Maria Gabriella Matera
    Pages 117-129

  8. Anti-IgE and Biologic Approaches for the Treatment of Asthma

    • Patrick D. Mitchell, Amani I. El-Gammal, Paul M. O’Byrne
    Pages 131-152

  9. Leukotriene Receptor Antagonists and Antiallergy Drugs

    • Tsutomu Tamada, Masakazu Ichinose
    Pages 153-169

  10. Glucocorticoids

    • Ian M. Adcock, Sharon Mumby
    Pages 171-196

  11. Bifunctional Drugs for the Treatment of Respiratory Diseases

    • Clive Page, Mario Cazzola
    Pages 197-212

  12. Drugs Affecting TRP Channels

    • M. A. Wortley, M. A. Birrell, M. G. Belvisi
    Pages 213-241

  13. Evaluation of New Drugs for Asthma and COPD: Endpoints, Biomarkers and Clinical Trial Design

    • Dave Singh
    Pages 243-264

  14. Drug Delivery Devices for Inhaled Medicines

    • Anne Lexmond, Ben Forbes
    Pages 265-280

  15. Back Matter

    Pages 281-285
    Download chapter PDF
Back to top

Keywords

About this book

The present volume is supposed to be a major reference resource for chest physicians and those involved in the development of novel pharmaceutical entities for these diseases. Internationally recognized authorities review the most important new information on the advances in our understanding of the pathogenesis and treatment of these diseases, including the substantial advances in the topical delivery of inhaled medicines. Each chapter is extensively referenced, generously illustrated with clear diagrams and photographs, and represents a state-of-the-art review of this important area of respiratory medicine.

Reviews

“This is an excellent guide to help readers understand the thinking behind management choices in asthma and chronic obstructive pulmonary disease. … This book, written by a respected group of international authors, will provide a valuable reference for both primary and secondary care clinicians as well as allied health professionals and students who are looking for succinct, up-to-date information to help them treat patients with asthma or chronic obstructive pulmonary disease.” (J. K. Quint, British Journal of Hospital Medicine, Vol. 78 (5), May, 2017)

Editors and Affiliations

  • Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King’s College London, London, United Kingdom

    Clive P. Page

  • Airway Disease Section, Imperial College, National Heart and Lung Institute, London, United Kingdom

    Peter J. Barnes

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation